Samlyn Capital, LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:59 pm Sale |
2024-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Samlyn Capital, LLC | 0 0.000% |
-3,372,558 (Position Closed) |
Filing |
| 2024-02-14 1:40 pm Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Samlyn Capital, LLC | 3,372,558 5.500% |
3,372,558 (New Position) |
Filing |